Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI coach may soothe the agony of Dialysis-Related itching

NCT ID NCT07740083

Symptom relief Sponsor: Izmir Tinaztepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study tests whether an artificial intelligence-supported education program can help reduce itching in people with chronic kidney disease who are on hemodialysis. The program teaches patients about causes of itching, skin care, diet, and self-management strategies through an AI-powered website. Researchers will measure changes in itching severity and patient empowerment. The goal is to see if better-informed patients can better manage this distressing symptom.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence-supported patient education program focused on pruritus management
What this could lead to
If effective, this approach could offer a non-drug way to reduce itching and improve self-care for people on dialysis.
What could go wrong
The trial is relatively small and the intervention is educational, so benefits may be modest or not generalize. Itching is complex and may not respond to education alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients with CKD. Patients who have ithing symptom. Patients who is older than 18. Patients who takes hemodylasis treatment regularly and in order. Exclusion Criteria: * Patients who got dementia and alzheimers. * Patients who is older than 65. * Patients who doesnt want to join the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronc kidney disease stage 5 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure impaired renal function disease kidney disorder Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronc kidney disease stage 5 Chronic kidney disease Kidney disease

Contacts and locations

Locations

  • Nursing

    Izmir, Ege, 35400, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.